Alain Algazi
Professor of Clinical Medicine · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
Research
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
New England Journal of Medicine · 2013 · 2,799 citations
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
New England Journal of Medicine · 2012 · 2,234 citations
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
New England Journal of Medicine · 2018 · 1,083 citations
33 papers
14 papers
12 papers · 8 as a fellow
11 papers
11 papers
11 papers
10 papers
10 papers
Grants
- 2026–2031
Restoring Responses to Immunotherapy in Metastatic Lymph Nodes in HNSCC
National Institute of Dental and Craniofacial Research · R01
PI · $684.8K · University of California, San Francisco
Clinical trials
- 2020–2024
Principal investigator · Withdrawn · Phase 2
Alain Algazi
- 2019–2027
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
Principal investigator · Active not recruiting · Phase 2
Alain Algazi
- 2014–2027
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
- 2013–2016
Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets
Study chair · Terminated · Phase 2
University of California, San Francisco